The pan-Canadian Pharmaceutical Alliance — the gate every public listing passes through. 4 pieces.
The pCPA's quiet two-year extension keeps Canada's generic savings flowing to 2028. It also runs straight through the window in which Washington decides whether to tariff the molecules underneath them.
pCPA · FormularyHealth Canada cleared two generic semaglutides inside four days. The story isn't the price drop everyone reported — it's that the country just rewired the dispensing economics of its single largest drug class, and the wiring is permanent.
pCPAA two-year extension of a generic-pricing agreement is the least glamorous item of the quarter. It also governs the economics beneath roughly four of every five prescriptions dispensed in Canada.
pCPAThe pCPA has split its negotiation pipeline into complex and non-complex tracks, and the channel-timeline consequences are larger than the procedural framing suggests.